July 17, 2022 Comments Off on New tentative approval for Eugia Pharma drug palbociclib Posted in: Tentative Approval Palbociclib is the generic ingredient in one branded drug marketed by Pfizer and is included in two NDAs. There are six patents protecting this compound. Drug patent litigation for PALBOCICLIB.…
The post New tentative approval for Eugia Pharma drug pal…
July 17, 2022 Comments Off on New patent expiration for Braintree drug AXID Posted in: Uncategorized
Annual Drug Patent Expirations for AXID Axid is a drug marketed by Smithkline Beecham, Braintree, and Glaxosmithkline and, and is included in three NDAs. There is one patent protecting this…
The post New patent expiration for Braintree drug AXID appear…
